Liu, F., Zhou, Q., Jiang, H., Zhang, T., Miao, C., Xu, X., . . . Chen, X. Q. (2023). Piperlongumine conquers temozolomide chemoradiotherapy resistance to achieve immune cure in refractory glioblastoma via boosting oxidative stress-inflamation-CD8+-T cell immunity. Journal of Experimental & Clinical Cancer Research, 42(1), 1. https://doi.org/10.1186/s13046-023-02686-1
Chicago-referens (17:e uppl.)Liu, Feng, et al. "Piperlongumine Conquers Temozolomide Chemoradiotherapy Resistance to Achieve Immune Cure in Refractory Glioblastoma via Boosting Oxidative Stress-inflamation-CD8+-T Cell Immunity." Journal of Experimental & Clinical Cancer Research 42, no. 1 (2023): 1. https://doi.org/10.1186/s13046-023-02686-1.
MLA-referens (9:e uppl.)Liu, Feng, et al. "Piperlongumine Conquers Temozolomide Chemoradiotherapy Resistance to Achieve Immune Cure in Refractory Glioblastoma via Boosting Oxidative Stress-inflamation-CD8+-T Cell Immunity." Journal of Experimental & Clinical Cancer Research, vol. 42, no. 1, 2023, p. 1, https://doi.org/10.1186/s13046-023-02686-1.
